Opinion
MISC. CASE NO. 16-mc-51
10-27-2016
GREGORY W. SLOAN, INVIDUALLY AND AS THE REPRESENTATIVE OF THE ESTATE OF WILLIAM OAKLEY SLOAN, PLAINTIFFS v. TAKED PHARMACEUTICALS AMERICA, INC.; TAKEDA PHARMACEUTICALS U.S.A., f/k/a TAKEDA PHARMACEUTICALS NORTH AMERCIA, INC., and TAKEDA PHARMACEUTICAL COMPANY LIMITED; DEFENDANTS
JUDGE DOHERTY
REPORT AND RECOMMENDATIONS ON UNOPPOSED MOTION FOR SETTLEMENT AS TO CLAIMS OF DECEDENT , WILLIAM OAKLEY SLOAN
This Court, having reviewed Plaintiffs' Unopposed Motion to Approve Settlement as to Claims of Gregory W. Sloan as Special Administrator and Derivative; and Theresa Sloan, Daniel L. Sloan and Debra Sloan Hixson as Derivative Claimants and Takeda Pharmaceutical Company Limited and Takeda Pharmaceuticals U.S.A., Inc. (collectively "Takeda"), the parties having received due notice of and having had the opportunity to be heard, and this Court having considered all submissions made, I recommend to the Court that the Motion be
GRANTED and
The settlement by and between Plaintiffs, Gregory W. Sloan as Special Administrator and Derivative; and Theresa Sloan, Daniel L. Sloan and Debra Sloan Hixson as Derivative Claimants individually and as legal heirs to the Estate of William Oakley Sloan deceased, and Takeda, as notice to the Court on October 25, 2016 be
APPROVED.
The Court has jurisdiction of this matter by virtue of the Plaintiffs participating in the Actos MDL Master Settlement Agreement.
ANY PARTY OBJECTING TO THIS RECOMMENDATION SHALL SUBMIT OBJECTIONS, IN WRITING, DIRECTLY TO JUDGE DOHERTY'S CHAMBERS - AND SHALL NOT FILE THE OBJECTION INTO THE RECORD - NO LATER THAN TEN (10) DAYS AFTER ENTRY OF THIS RECOMMENDATION.
If there is no objection within ten (10) days of the entry of this Recommendation, the Recommendation will become an Order.
This is DONE AND SIGNED in Lafayette, Louisiana, this 27th of October, 2016.
/s/_________
HONORABLE PATRICK J. HANNA
UNITED STATES MAGISTRATE JUDGE